FindTrial
Sign In

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524334-26-01
Enrollment
15
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or metastatic breast cancer, Advanced or metastatic solid tumors, Endometrial cancer (EC), Gastroesophageal cancer (GEC), High grade serous ovarian cancer (HGSOC), Platinum-resistant ovarian cancer (PROC)

Interventions

None listed

Sponsors

Bristol-Myers Squibb Services Unlimited Company
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 27, 2026